UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

Thorax, 2013-09, Vol.68 (9), p.818-825

2013

Volltextzugriff (PDF)

Microbial pathogenesis in cystic fibrosis : Mucoid Pseudomonas aeruginosa and Burkholderia cepacia

Microbiological reviews, 1996-09, Vol.60 (3), p.539-574

1996

Volltextzugriff (PDF)

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

The European respiratory journal, 2002-09, Vol.20 (3), p.658-664

2002

Volltextzugriff (PDF)

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis

Thorax, 2004-11, Vol.59 (11), p.948-951

2004

Volltextzugriff (PDF)

Taxonomy and identification of the Burkholderia cepacia complex

Journal of clinical microbiology, 2001-10, Vol.39 (10), p.3427-3436

2001

Volltextzugriff (PDF)

Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?

Journal of antimicrobial chemotherapy, 2010-11, Vol.65 (11), p.2373-2375

2010

Volltextzugriff (PDF)

Assessment of Fluorescent In Situ Hybridization and PCR-Based Methods for Rapid Identification of Burkholderia cepacia Complex Organisms Directly from Sputum Samples

Journal of Clinical Microbiology, 2007-06, Vol.45 (6), p.1920-1926

2007

Volltextzugriff (PDF)

Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex

Journal of Clinical Microbiology, 2000-02, Vol.38 (2), p.910-913

2000

Volltextzugriff (PDF)

Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov

International journal of systematic and evolutionary microbiology, 1999-04, Vol.49 Pt 2 (2), p.405-413

1999

Volltextzugriff (PDF)

Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak

Thorax, 2003-06, Vol.58 (6), p.525-527

2003

Volltextzugriff (PDF)

Mechanism of Conversion to Mucoidy in Pseudomonas aeruginosa Infecting Cystic Fibrosis Patients

Proceedings of the National Academy of Sciences - PNAS, 1993-09, Vol.90 (18), p.8377-8381

1993

Volltextzugriff (PDF)

Burkholderia cepacia: medical, taxonomic and ecological issues

Journal of medical microbiology, 1996-12, Vol.45 (6), p.395-407

1996

Volltextzugriff (PDF)

Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy

Journal of Clinical Microbiology, 2005-10, Vol.43 (10), p.5136-5142

2005

Volltextzugriff (PDF)

Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens

FEBS letters, 1999-06, Vol.452 (3), p.309-313

1999

Volltextzugriff (PDF)

Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa

Thorax, 2002-11, Vol.57 (11), p.924-925

2002

Volltextzugriff (PDF)

P168 Eradication of Burkholderia cepacia in CF: time for a coordinated approach?

Thorax, 2011-12, Vol.66 (Suppl 4), p.A135-A136

2011

Volltextzugriff (PDF)

Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation

Thorax, 2004-06, Vol.59 (6), p.526-528

2004

Volltextzugriff (PDF)

Antimicrobial Activity of Murine Lung Cells against Staphylococcus aureus Is Increased In Vitro and In Vivo after Elafin Gene Transfer

Infection and Immunity, 2005-06, Vol.73 (6), p.3609-3617

2005

Volltextzugriff (PDF)

Multidrug-resistant pulmonary infection in cystic fibrosis--what does 'resistant' mean?

Journal of medical microbiology, 2006-12, Vol.55 (Pt 12), p.1615-1617

Govan, J R W

2006

Volltextzugriff (PDF)

Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic

The Lancet (British edition), 1996-09, Vol.348 (9028), p.639-642

1996

Volltextzugriff (PDF)

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

The Lancet (British edition), 1993-07, Vol.342 (8862), p.15-19

1993

Volltextzugriff (PDF)

Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients

The Journal of hospital infection, 2003-06, Vol.54 (2), p.120-123

2003

Volltextzugriff (PDF)

Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients

The European respiratory journal, 2004-06, Vol.23 (6), p.851-856

2004

Volltextzugriff (PDF)

Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples

International journal of systematic and evolutionary microbiology, 2001-05, Vol.51 (3), p.1099-1107

2001

Volltextzugriff (PDF)

Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?

The European respiratory journal, 2011-12, Vol.38 (6), p.1483-1486

2011

Volltextzugriff (PDF)

1 – 25 von 467

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(396)
Mit Volltextzugriff
(364)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(305)
Life Sciences & Biomedicine
(271)
Humans
(234)
Biological And Medical Sciences
(138)
Female
(108)
Microbiology
(94)
Medical Sciences
(86)
Male
(79)
Fundamental And Applied Biological Sciences. Psychology
(65)
Cystic Fibrosis - Microbiology
(62)
Adult
(57)
Infectious Diseases
(54)
Cystic Fibrosis
(51)
Middle Aged
(48)
Pseudomonas Aeruginosa
(48)
Bacteriology
(45)
General & Internal Medicine
(43)
Burkholderia Cepacia
(37)
Animals
(36)
Medicine, General & Internal
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

Microbial pathogenesis in cystic fibrosis : Mucoid Pseudomonas aeruginosa and Burkholderia cepacia

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis

Taxonomy and identification of the Burkholderia cepacia complex

Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?

Assessment of Fluorescent In Situ Hybridization and PCR-Based Methods for Rapid Identification of Burkholderia cepacia Complex Organisms Directly from Sputum Samples

Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex

Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov

Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak

Mechanism of Conversion to Mucoidy in Pseudomonas aeruginosa Infecting Cystic Fibrosis Patients

Burkholderia cepacia: medical, taxonomic and ecological issues

Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy

Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens

Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa

P168 Eradication of Burkholderia cepacia in CF: time for a coordinated approach?

Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation

Antimicrobial Activity of Murine Lung Cells against Staphylococcus aureus Is Increased In Vitro and In Vivo after Elafin Gene Transfer

Multidrug-resistant pulmonary infection in cystic fibrosis--what does 'resistant' mean?

Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients

Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients

Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples

Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?

Suchergebnisse filtern